VTAK
Catheter Precision Inc.
NYSE MKT: VTAK · HEALTHCARE · MEDICAL DEVICES
$0.94
+0.77% today
Updated 2026-04-29
Market cap
$2.51M
P/E ratio
—
P/S ratio
3.07x
EPS (TTM)
$-15.90
Dividend yield
—
52W range
$1 – $16
Volume
1.4M
Catheter Precision Inc. (VTAK) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.89M | $-5.52M | $-18.51M | $-33.17M | $-28.30M | $-27.63M | $-22.57M | $-20.62M | $-9.27M | $-8.30M |
| Capital expenditures | $210000.00 | $547000.00 | $582000.00 | $268000.00 | $67000.00 | $265000.00 | $17000.00 | $76000.00 | $67000.00 | $17000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $2.30M | $12.71M | $14.73M | $23.54M | $4.08M | $2.24M | $447000.00 | $1.22M | $54000.00 | $338000.00 |
| Free cash flow | $-2.10M | $-6.07M | $-19.09M | $-33.44M | $-28.37M | $-27.89M | $-22.59M | $-20.70M | $-9.34M | $-8.31M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | $907161.00 | — | $5.16M | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — |